Literature DB >> 19493693

Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations.

H Senta1, H Park, E Bergeron, O Drevelle, D Fong, E Leblanc, F Cabana, S Roux, G Grenier, N Faucheux.   

Abstract

The bone morphogenetic proteins (BMPs) are cytokines of the transforming growth factor beta family. Some BMPs such as BMP-2 and BMP-7 play a major role in the development of the skeleton and the maintenance of homeostasis during bone remodelling. To date, only BMP-2 and BMP-7 have been approved by the Food and Drug Administration for specific orthopaedic applications. However, due to BMP cost, peptides derived from their knuckle epitope with osteogenic properties have been developed. BMPs are involved in many other biological events, including embryogenesis, angiogenesis and cancer. BMPs therefore have great biomedical potential as osteogenic factors and as anti-cancer agents. This review focuses on the use of BMPs and their derived peptides in biomedical delivery systems and gene therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19493693     DOI: 10.1016/j.cytogfr.2009.05.006

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  19 in total

Review 1.  Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression.

Authors:  Kyobum Kim; Andrew Yeatts; David Dean; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

2.  FOXO1 modulates osteoblast differentiation.

Authors:  Michelle F Siqueira; Stephen Flowers; Rupa Bhattacharya; Dan Faibish; Yugal Behl; Darrell N Kotton; Lou Gerstenfeld; Elizabeth Moran; Dana T Graves
Journal:  Bone       Date:  2011-01-28       Impact factor: 4.398

3.  Enhancement of the Regenerative Potential of Anorganic Bovine Bone Graft Utilizing a Polyglutamate-Modified BMP2 Peptide with Improved Binding to Calcium-Containing Materials.

Authors:  Jennifer L Bain; Paul P Bonvallet; Ramzi V Abou-Arraj; Peter Schupbach; Michael S Reddy; Susan L Bellis
Journal:  Tissue Eng Part A       Date:  2015-09       Impact factor: 3.845

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

Review 5.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

6.  Presentation of BMP-2 mimicking peptides in 3D hydrogels directs cell fate commitment in osteoblasts and mesenchymal stem cells.

Authors:  Christopher M Madl; Manav Mehta; Georg N Duda; Sarah C Heilshorn; David J Mooney
Journal:  Biomacromolecules       Date:  2014-01-08       Impact factor: 6.988

7.  Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H.

Authors:  Tao Shen; Chuang Sun; Zhengmao Zhang; Ningyi Xu; Xueyan Duan; Xin-Hua Feng; Xia Lin
Journal:  Cell Res       Date:  2014-04-15       Impact factor: 25.617

8.  Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy.

Authors:  Michal Kuczma; Agnieszka Kurczewska; Piotr Kraj
Journal:  J Immunotoxicol       Date:  2013-12-19       Impact factor: 3.000

Review 9.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

10.  Inhibitory effect of bone morphogenetic protein-2 on the proliferation of giant cell tumor of bone stromal cells in vitro.

Authors:  Baohua He; Guanping He; Xiaofei Zheng; Lihua Li; Mei Li; Hong Xia
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.